AmerisourceBergen Corporation (ABC)
| Market Cap | 24.63B |
| Revenue (ttm) | 196.28B |
| Net Income (ttm) | -3.75B |
| Shares Out | 204.92M |
| EPS (ttm) | -18.34 |
| PE Ratio | n/a |
| Forward PE | 14.25 |
| Dividend | $1.72 |
| Dividend Yield | 1.43% |
| Trading Day | May 12 |
| Last Price | $120.09 |
| Previous Close | $120.10 |
| Change ($) | -0.01 |
| Change (%) | -0.01% |
| Day's Open | 120.04 |
| Day's Range | 119.09 - 120.66 |
| Day's Volume | 1,017,171 |
| 52-Week Range | 80.10 - 125.86 |
AmerisourceBergen Corporation (NYSE: ABC) shares dropped after the company's Q2 for fiscal 2021 failed to meet the consensus estimates. It reported an adjusted EPS of $2.53 topped the analyst consensus ...
AmerisourceBergen's (ABC) fiscal second-quarter results benefit from segmental growth.
AmerisourceBergen (ABC) delivered earnings and revenue surprises of 0.80% and -1.58%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 second quarter ended March 31, 2021, revenue increased 3.7 percent year-over-yea...
AmerisourceBergen (ABC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
AmerisourceBergen's (ABC) fiscal second-quarter results are likely to reflect solid performance at Pharmaceutical Distribution and Other units.
AmerisourceBergen (ABC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AmerisourceBergen (ABC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches.
AmerisourceBergen (ABC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Today, global healthcare company AmerisourceBergen launched the Accelerate Specialty Network (Accelerate), the nation's first specialty-focused Pharmacy Services Admi...
VALLEY FORGE, Pa.--(BUSINESS WIRE)--The AmerisourceBergen Foundation, an independent not-for-profit charitable giving organization focused on supporting health-related causes that enrich the global comm...
AmerisourceBergen (ABC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Second Quarter of Fiscal 2021 on Wednesday, May 5, 2021, prior ...
VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced the closing of its public offering of $1,525,000,000 aggregate principal amount of its 0.737% Senior Notes d...
AmerisourceBergen (ABC) is optimistic about maintaining a robust segmental performance amid the pandemic-led business disruptions.
VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it priced $1.525 billion aggregate principal amount of its 0.737% Senior Notes due March 15, 2023 (the ...
AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches.
AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock?
AmerisourceBergen CEO on how U.S. vaccine distribution is going
Steve Collis, AmerisourceBergen CEO, joins 'Squawk on the Street' to discuss the role his company has played in the federal retail pharmacy program and his thoughts on the vaccine distribution.
These companies are delivering strong results of late, and there's reason to be optimistic about what's coming next.
VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen, a global healthcare company, released its 2020 Global Sustainability Report and ESG Reporting Index, detailing the impact of its robust sustainabil...
AmerisourceBergen's (ABC) fiscal first-quarter results benefit from segmental growth.
AmerisourceBergen (ABC) delivered earnings and revenue surprises of 12.37% and 3.84%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 first quarter ended December 31, 2020, revenue increased 9.7 percent year-over-y...
AmerisourceBergen (ABC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
VALLEY FORGE, Pa.--(BUSINESS WIRE)--Today, AmerisourceBergen kicked off its first-ever ThinkLive Commercialization global event, a new extension to its annual manufacturer summit centered on strategies ...
AmerisourceBergen's (ABC) fiscal first-quarter results are likely to reflect solid performance at Pharmaceutical Distribution and Other units.
AmerisourceBergen (ABC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
When looking for value opportunities, one method is to choose stocks whose trailing 12-month price-to-free-cash-flow ratios are low compared to that of the S&P 500 index, which stands at 15.28 as of the...
AmerisourceBergen (ABC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest v...
VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that its Board of Directors declared a quarterly dividend of $0.44 per common share, payable March 1, 2021, ...
AmerisourceBergen (ABC) and Walgreens (WBA) enter into a key strategic deal to boost focus on core businesses, while extending their partnership.
Walgreens Boots Alliance Inc (NASDAQ: WBA) disclosed on Wednesday that it had signed an agreement with healthcare products distributor AmerisourceBergen Corp (NYSE: ABC) to sell a majority stake in its ...
In an announcement on Wednesday, Walgreens Boots Alliance Inc (NASDAQ: WBA) said it will sell its distribution business to AmerisourceBergen Corp (NYSE: ABC) for £4.78 billion. Walgreens shares were see...
The shares of Walgreens Boots Alliance Inc (NASDAQ: WBA) are up 2.5% to trade at $42.18 this morning, after it was reported that the company is selling its Alliance Healthcare businesses to AmerisourceB...
The large drug wholesaler AmerisourceBergen will acquire the majority of Walgreens Boots Alliance's “Alliance Healthcare business” for $6.5 billion, the companies announced Wednesday.
AmerisourceBergen also raised its guidance, sending shares up more than 6% in early Wednesday trade
Drug distributor AmerisourceBergen Corp said on Wednesday it would buy Walgreens Boots Alliance's distribution business, Alliance Healthcare, for $6.5 billion.
VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today updated its fiscal year 2021 financial guidance to reflect the Company's continued strong operating income performance...
VALLEY FORGE, Pa. & DEERFIELD, Ill.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) and Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced strategic agreements under which Amerisou...
AmerisourceBergen is a pharmaceutical distribution company that has seen solid earnings and revenue growth. The company does have a deal with the CDC to handle the distribution of COVID vaccines to inde...
VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the First Quarter of Fiscal 2021 on Thursday, February 4, 2021, pri...
AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches.
AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock?
Let's see if AmerisourceBergen (ABC) stock is a good choice for value-oriented investors right now from multiple angles.
VALLEY FORGE, Pa.--(BUSINESS WIRE)--As part of its commitment to fostering a diverse and inclusive culture, AmerisourceBergen, a global healthcare solutions leader, announced the appointment of Dr. Loni...
About ABC
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alter... [Read more...]
| Industry Medical Distribution | IPO Date Apr 4, 1995 |
| CEO Steven Collis | Employees 22,000 |
| Stock Exchange NYSE | Ticker Symbol ABC |
Analyst Forecasts
According to 19 analysts, the average rating for ABC stock is "Buy." The 12-month stock price forecast is 129.93, which is an increase of 8.19% from the latest price.